CA
NZ
UK
AU
IND
US
Eco-Growth Strategies is a Hawaii-basedBusinessnow centered on premium bottled water production and distribution, having historically described itself as a provider of design-build infrastructure services, including telecommunications work. The company trades on the U.S. over-the-counter market, not a national exchange. Through 2026 it has publicized …
Organogenesis is a regenerative-medicine company focused on advanced wound care and surgical and sports medicine, with a portfolio that has long included skin-substitute and tissue products such as Apligraf and Dermagraft. In the second quarter of 2026, the company reported revenue of $42.8 million, …
Few tickers illustrate the hazards of nano-cap trading better than Greater Cannabis Co Inc (OTC:GCAN). The share registry still lists the name Greater Cannabis Co Inc, yet theBusinessbehind it has quietly reinvented itself in 2026, walking away from cannabinoid research and toward financial services …
America Great Health describes itself as a biotechnology company focused on theResearch and Developmentof protein and peptide small-molecule drugs, alongside interests spanning AI-based diagnostic devices, cell therapy and regenerative medicine. The company is based in Alhambra, California, and was formerly known as Crown Marketing …
Nascent Biotech is a clinical-stage biopharmaceutical company developing Pritumumab, a natural human monoclonal antibody. The company has positioned Pritumumab as a treatment candidate for brain cancers such as glioblastoma, as well as epithelial cancers including lung, breast, colon and pancreatic tumors. Its most recent …
Acura is a drug-delivery company built around abuse-deterrent pharmaceutical technologies, including its Aversion and LIMITx platforms designed to reduce the potential for misuse of oral medications. Its portfolio has included Oxaydo, an immediate-release oxycodone product, and the Nexafed line of pseudoephedrine-based cold and allergy …
MoonLake is a clinical-stage biopharmaceutical company developing sonelokimab, a Nanobody designed to inhibit IL-17A and IL-17F, cytokines central to inflammatory disease. On August 10, 2026, the company announced positive topline results from its Phase 3 IZAR-1 trial of sonelokimab in psoriatic arthritis (PsA), reporting …
iTonic Holdings Ltd (NASDAQ: ITOC) is a healthcare technology company focused on brachytherapy, a form of cancer treatment that places radioactive sources inside or next to a tumor. The company develops treatment-planning systems and related software used in radiotherapy, and it is headquartered in …
Pulmatrix, Inc (NASDAQ: PULM) is a clinical-stage biotechnology company historically known for its iSPERSE inhaled dry-powder platform. In recent quarters it has functioned largely as a small, cash-conserving Nasdaq-listed shell seeking a strategic combination.
CalciMedica, Inc (NASDAQ: CALC) is a clinical-stage biopharmaceutical company developing Auxora, an intravenous inhibitor of calcium release-activated calcium (CRAC) channels. Its primary focus is acute pancreatitis (AP), a serious inflammatory condition with no approved targeted therapy.
Please wait processing your request...